	Attributable fraction of cardiac disease following radiotherapy among breast cancer survivors: a systematic review and meta-analysis. J Radiat Res Lee J, Park EJ, Bwogi E, Hamada N, Shim SR, Kwon D, Lee WJ. PMID: 42765659 [PubMed - as supplied by publisher]
	Development of a Consensus-Based Risk Stratification Algorithm for HR+/HER2- Early Breast Cancer to Guide Adjuvant CDK4/6i Therapy: Outcomes from a Multidisciplinary Workshop in India. Breast Cancer (Dove Med Press) Mallavarapu KM, Reddy B R, Sp S, Goyal P, Sathyanarayanan V, Rauthan A, Bajpai J, Bhargava PG, Agarwal M, Pinninti R, Chennamaneni R, Chaitanya P K, Bala SC, Pydi VR, Dev R, Dattatreya PS, Batra U, K GB, Shetty D, Paul K, Rathi P, Basade M. PMID: 42764958 [PubMed]
	Evaluation of the Feasibility, Safety, and Effectiveness of a Tailored Enhanced Recovery After Surgery Protocol for Gastroepiploic Vascularized Lymph Node Transfer in Breast Cancer-Related Upper Extremity Lymphedema: A Preliminary Retrospective Comparative Study. Microsurgery Lo Torto F, Dribine B, Pagnotta A, Loreti A, Cavallaro G. PMID: 42764541 [PubMed - indexed for MEDLINE]
	Prevalence and Determinants of Depression, Anxiety, and Quality of Life in Patients With Breast Cancer in Saudi Arabia: A Focus on Adjuvant Pharmacotherapy. Cancer Med Abdallah MS, Gardouh AR, Abuaeaaq ZK, Badawoud AM. PMID: 42764238 [PubMed - indexed for MEDLINE]
	Stereotactic ablative radiotherapy for oligometastatic breast cancer: A systematic review and meta-analysis (SABRINA). Radiother Oncol Viani GA, Hamamura AC, Arruda CV, Cardoso CE, Salmon HA, Amaral GO. PMID: 42764105 [PubMed - as supplied by publisher]
	Biomaterial-based mitochondria-targeted nanomedicine for remodeling the breast cancer tumor microenvironment and overcoming therapy resistance. Crit Rev Oncol Hematol Gu Y, Qu P, Li X, Shi J, Zhou M, Bai Z, Li G, Cheng P, Li X, Chen F, Liang Q. PMID: 42764101 [PubMed - as supplied by publisher]
	The 5-Lipoxygenase Pathway in Ovarian Cancer: Mechanisms of Metastasis, Chemoresistance, and Translational Targeting. Int J Womens Health Li M, Zhu X, Gan L, Jiang H. PMID: 42763661 [PubMed]
	Serum lipidomic profiles associated with Mediterranean diet in overweight and obese breast cancer survivors: an exploratory study. Eur J Nutr Lee JH, Park JS, Park JJ, Lee JW, Chu SH, Lee HW, Yoon YR, Seong SJ, Gwon MR. PMID: 42763329 [PubMed - indexed for MEDLINE]
	Metabolic Reprogramming Of Macrophages In Breast Cancer: Mechanisms And Therapeutic Implications. Cancer Treat Res Commun Zhang J, Yang R. PMID: 42762607 [PubMed - as supplied by publisher]
	Exploring the perceived need and anticipated feasibility of a proposed nurse-led telephone follow-up approach for breast cancer survivors in India: A convergent mixed methods study. Eur J Oncol Nurs Nair A, Brown JA, Halkett GKB, Yadav BS, Kendall G, Chih H, Kumar A, Duggan R. PMID: 42762589 [PubMed - as supplied by publisher]
	70-gene signature MammaPrint for early-stage HR-positive, HER2-negative breast cancer: Outcome in the MINDACT trial for key clinical-pathological high-risk subgroups. Eur J Cancer Gielen RCAM, Poncet C, van 't Veer LJ, Rubio IT, Delaloge S, Pierga JY, Brain E, Vrijaldenhoven S, Neijenhuis PA, Ignatiadis M, Viale G, Cardoso F, Piccart M, Rutgers EJT, Kok M, Drukker CA. PMID: 42762561 [PubMed - as supplied by publisher]
	Regional Diversity of Human Papillomavirus Genotypes in Southeastern Brazil: Implications for Cervical Cancer Screening. J Med Virol Dalvi DD, Cruz AMG, de Oliveira Rocha PS, Dos Passos Segantine ER, Grillo D, Goulart JP, Miranda AE, Ribeiro-Rodrigues R. PMID: 42762472 [PubMed - indexed for MEDLINE]
	Breast and colorectal cancer screening and staging diagnosis among people with and without HIV. AIDS Care King M, Nguyen N, Gao D, Sarria J, Li CY, Kuo YF, Yu X. PMID: 42762440 [PubMed - as supplied by publisher]
	Summary of Research: HER2CLIMB-05: A Phase III Study of Tucatinib Versus Placebo in Combination with Trastuzumab and Pertuzumab as First-Line Maintenance Therapy for HER2+ Metastatic Breast Cancer. Target Oncol Dieras V, Curigliano G, Martin M, Lerebours F, Tsurutani J, Savard MF, Jerzak KJ, Hu X, O'Sullivan CC, Tokunaga E, Okines A, Huang CS, Jacot W, Sohn J, Cronemberger Silva E, Mueller V, Yang S, Granata G, Shen Q, Hamilton E, HER2CLIMB-05 Investigators. PMID: 42762393 [PubMed - as supplied by publisher]
	Five-year outcomes of partial breast proton beam therapy without lumpectomy for early-stage breast cancer: an interventional prospective study. Breast Cancer Ogo E, Arimura T, Ogino T, Toh U, Murotani K, Isomoto I, Kubo M, Nishimura R, Miyata Y, Suzuki G, Hishikawa Y, Mitsuyama S, Nagata R. PMID: 42762384 [PubMed - as supplied by publisher]
	Association of statin use and left ventricular function in patients with breast cancer receiving trastuzumab. Am Heart J Plus Nochioka K, Terui Y, Udagawa A, Kato S, Toyoda S, Shimojima M, Izumiya Y, Yano T, Kitai T, Yasuda S, Sugimura K. PMID: 42761834 [PubMed]
	Lobular breast cancer and prognosis: what should we tell patients? Front Oncol Kulasegaran T, Beecher K, Kinnon P, Lakhani SR, Simpson PT, McCart Reed AE. PMID: 42761746 [PubMed]
	Cardiotoxicity in breast cancer patients treated with chemoradiotherapy. Explor Target Antitumor Ther Emerson P, Thomas L. PMID: 42761676 [PubMed]
	Spatial architecture of tumor-infiltrating lymphocytes adds predictive value beyond stromal TIL density for neoadjuvant response in triple-negative breast cancer. Front Immunol Yang K, Huang H, Shen W, Liu Y, Gao D, Hao T, Zhou H, Huang Y. PMID: 42761618 [PubMed - indexed for MEDLINE]
	Post-CDK4/6 inhibitor therapy in HR+/HER2- advanced breast cancer: expanding options and persisting uncertainties. Explor Target Antitumor Ther Hollinger AM, Bill R. PMID: 42761341 [PubMed]

Articles 1 - 20 / 335397

Page 1 of 16770



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy